acute treatment of migraine Archives - CDR

Dr. Reddy’s gets FDA approval for Tosymra

January 28, 2019 by Chain Drug Review acute treatment of migraine, Dr. Anil Namboodiripad, Dr. Reddy's Laboratories, G.V. Prasad, Promius Pharma, Tosymra nasal spray Pharmacy, Supplier News

PRINCETON, N.J. — Dr. Reddy’s Laboratories and its subsidiary, Promius Pharma. today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA). Tosymra is indicated for the acute treatment of migraine with or without aura in adults. Tosymra is the latest product to join the Promius Pharma acute migraine treatment

Eli Lilly to acquire CoLucid for $960 million

January 19, 2017 by Chain Drug Review acute treatment of migraine, CoLucid Pharmaceuticals, David Ricks, Eli Lilly, migraine medication, Thomas Mathers Business, Supplier News

INDIANAPOLIS — Eli Lilly and Co. plans to buy CoLucid Pharmaceuticals Inc., maker of a promising migraine medication, for about $960 million in cash. Cambridge, Mass.-based CoLucid is currently in development with lasmiditan tablets, indicated for acute treatment of migraine, and has completed the first of two Phase 3 trials. A data read-out for the